Robust Process Solutions To Purify GLP-1 Receptor Agonists

GLP-1 agonists represent a promising advancement in treating diabetes and obesity, highlighting the potential of peptide-based therapies. This webinar explores effective strategies for producing master GLP-1 agonists as well as proven technologies specifically designed for peptide therapeutics, with an emphasis on GLP-1. Watch to learn how to optimize GLP-1 production, how throughput and performance affect downstream processes in protein therapies, and how to enhance yield and purity for optimal process outcomes.